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KAJIAN HEPATOPROTAKTIF DAN FARMAKOLOGI EKSTRAK ETANOL 
TERPIAWAI CURCUMA XANTHORRHIZA ROXB.  
ABSTRAK 
Sifat hepatoprotektif dan farmakologi ekstrak rizom C. xanthorrhiza telah dinilai 
menggunakan model esei in vivo dan in vitro. Sebelum bioesei, pengekstrakan cecair 
terpilih dilakukan ke atas ekstrak etanol daripada rizom C. xanthorrhiza menghasilkan 
fraksi heksana, etil asetat dan air. Xanthorrhizol digunakan sebagai penanda untuk 
pempiawaian ekstrak etanol dan semua fraksi daripada rizom C. xanthorrhiza. Kehadiran 
terpenoid, flavonoid, glikosida kardiak dan saponin dapat diperhatikan melalui analisis 
kuantitatif penyaringan fitokimia di dalam ekstrak rizom etanol terpiawai C. xanthorrhiza 
(CXRE). Ketoksikan akut secara oral CXRE menunjukkan LD50 melebihi 5,000 mg/kg, 
menunjukkan CXRE adalah selamat untuk digunakan untuk penyelidikan pre-klinikal 
pada haiwan. Ujian seterusnya ke atas aktiviti antioksida pada CXRE dan fraksi (heksana, 
etil asetat dan air) telah dijalankan. Esei FRAP, DPPH dan ABTS menunjukkan aktiviti 
antioksida yang paling tinggi dalam fraksi heksana berbanding ekstrak etanol C. 
xanthorrhiza, fraksi etil asetat dan fraksi air, selari dengan kandungan fenolik dan 
flavonoid total. Kandungan fenolik dan flavonoid total fraksi heksana masing-masing 
ialah 61.00 mg GAE/g dan 92.80 mg CAE/g. Fraksi heksana rizom C. xanthorrhiza yang 
telah dipiawaikan (CXRH) pada dos 125, 250 dan 500 mg/kg telah digunakan untuk 
menilai aktiviti hepatoprotaktif ke atas tikus yang mengalami kerosakan hepar setelah 
diinduksi dengan carbon tetraklorida (CCl4). Enzim-enzim hepar (ALT, AST dan ALP), 
trigliserida, protein serum total menunjukkan penurunan yang signifikan dengan 
peningkatan pada paras enzim antioksidatif (SOD, CAT, GPx dan GR) dan kandungan 
xviii 
 
protein total pada hepar dalam tikus yang dirawat dengan  berbanding dengan kumpulan 
yang dirawat dengan CCl4. CXRH juga didapati memperbaiki aktiviti peroksidasi lipid 
dan menunjukkan pemulihan pada tisu hepar yang dirosakkan oleh CCl4. Aktiviti 
farmakologi seterusnya dikaji untuk aktiviti antinosiseptif dalam tikus dengan 
menggunakan 3 model yang berbeza iaitu plat panas, jentik ekor dan ujian sakit induksi 
formalin. CXRE tidak menunjukkan aktiviti antinosiseptif yang signifikan dalam model 
sakit akut tetapi berupaya menekan fasa awal (mekanisme tindakan pusat) dan inflamasi 
neurogenik (mekanisme tindakan periferi) yang memerlukan penyelidikan lanjut untuk 
menjelaskan mekanisma yang terlibat. 
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HEPATOPROTECTIVE AND PHARMACOLOGY STUDIES OF 
STANDARDIZED ETHANOLIC EXTRACT OF  
CURCUMA XANTHORRHIZA ROXB. 
ABSTRACT 
The hepatoprotective and pharmacology properties of C. xanthorrhiza rhizome extracts 
were investigated using in vivo and in vitro model assays. Prior to the bioassays, C. 
xanthorrhiza rhizome ethanolic extract (CXRE) were subjected to liquid-liquid extraction 
resulting in hexane, ethyl acetate and water fractions. Xanthorrhizol was employed as the 
marker to standardize the CXRE and fractions respectively. The presence of terpenoids, 
flavonoids, cardiac glycosides and saponin were observed in the standardized CXRE 
through qualitative phytochemical screening analysis. The acute oral toxicity of 
standardized CXRE showed an LD50 of greater than 5,000 mg/kg, indicating CXRE is 
relatively safe for preclinical investigation in animals. Further, the standardized CXRE 
and its fractions (hexane, ethyl acetate and water) were tested for antioxidant activity. In 
FRAP, DPPH and ABTS assay, the highest antioxidant activity was found in hexane 
fraction compared to the CXRE, ethyl acetate fraction and water fractions in line with 
their total phenolics and flavonoids content. The total phenolics and flavonoids content of 
hexane fraction were 61.00 mg GAE/g and 92.80 mg CAE/g respectively. The 
standardized C. xanthorrhiza rhizome hexane fraction (CXRH) at doses 125, 250 and 500 
mg/kg was further tested for hepatoprotective activity against CCl4- induced hepatic 
damage in rats. The liver enzymes (ALT, AST, and ALP), triglycerides, total serum 
protein showed significant decrease with a substantial increase in the antioxidative 
enzyme levels (SOD, CAT, GPx, and GR) and total protein content of the liver in 
xx 
 
standardized CXRH treated rats as opposed to CCl4–treated groups. Standardized CXRH 
was also found to ameliorate the lipid peroxidation activity and showed a good recovery 
of the CCl4 damaged hepatic tissues. The pharmacological activity of standardized CXRE 
was further studied for its antinociceptive activity in rats using three different models, 
namely the hot plate test, tail flick test and formalin-induced pain test. CXRE did not 
show significant antinociceptive in acute pain model but was able to suppress the early 
phase (central acting mechanism) and neurogenic inflammation (peripheral acting 
mechanism) which requires further investigation to elucidate the exact mechanism 
involved.  
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CHAPTER ONE 
  INTRODUCTION 
1.1  Role of plants as medicine 
Medicinal plants have played a key role in world health. According to WHO, 80% of 
the world‘s populations rely on plant-derived medicines for their healthcare (WHO, 2002). 
Medicinal plants are distributed worldwide, but they are most abundant in tropical 
countries. It is estimated that about 25% of all modern medicines are directly or indirectly 
derived from higher plants (Majno, 1991; Farnsworth and Morris, 1976). Enhancement of 
such practices lead to the well-established Asian systems of medicines including Ayurveda 
and Siddha of India, Unani system of middle and Far East Asia, Ying and Yang principles 
of Chinese herbal medicines,  Jamu of Indonesia and others (Sharma et al., 1998; Natesh, 
2000). About 400 plant species are used in regular production of Ayurvedic, Unani, Siddha 
and tribal medicine (Rajasekharan and Ganeshan, 2003). It is also a fact that one quarter of 
all medical prescriptions are formulations based on substances derived from plants. It is 
likely that the profound knowledge of herbal remedies in traditional cultures developed 
through trial and error over many centuries, and was passed on verbally from one 
generation to another (Bensky and Gamble, 1993). 
It is estimated that around 122 pure chemical constituents were isolated from higher 
plants throughout the world. One of the classic examples is vincristine and vinblastine 
isolated from Catharanthus roseus, Apocynaceae. Vinblastine isolated from the 
Catharanthus rosesus is used for the treatment of Hodgkins, choriocarcinoma, non-
hodgkins lymphomas, leukemia in children, testicular and neck cancer (Farnsworth et al., 
1967). Vincristine is recommended for acute lymphocytic leukemia in childhood advanced 
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stages of Hodgkins, lymophosarcoma, cervical and breast cancer (Farnsworth and Bingel, 
1977). Phophyllotoxin, a constituent isolated from Phodophyllum emodi is another good 
example of drug used against testicular, small cell lung cancer and lymphomas. There are 
many drugs that are commonly used today, for instances, aspirin, ephedrine, ergometrine, 
tubocurarine, digoxin, galanthamine and apomorphine which has been derived through 
indigenous medicine via bioscientific investigations of plants (Duke and Martinez, 1994). 
In fact, nature has bestowed some plants with the property to prevent, treat and cure 
hepatic disturbances with interception of fewer side effects. Hepatoprotectives are a class 
of therapeutic agents that includes synthetic as well as natural product which offer 
protection to liver from damage or assist in regeneration of hepatic cells (Craker and 
Simon, 1990). Medicinal herbs are significant source of hepatoprotective drugs. It has been 
reported that about 170 phytoconstituents isolated from 110 plants belonging to 55 families 
do possess hepatoprotective activity (Handa, 1991). In general, liver protective herbal 
drugs contain a variety of chemical constituents like phenols, coumarins, curcuminoids, 
lignans, essential oils and terpenoids. Clinical research has also shown that herbals have 
genuine utility in the treatment of liver diseases. However, only a small portion of 
hepatoprotective plants as well as formulations used in traditional medicine are 
pharmacologically evaluated for its efficacy (Handa, 1991).  
Scientific research in ethnomedicine is ongoing and is growing rapidly especially in 
countries like Malaysia which has an abundance of natural resources. In the recent years, 
Malaysian government has shown interest in Malaysian herbal industry which was in line 
with the National Agricultural Policy (1998-2010) for herbal cultivation.  In addition, the 
Ministry of Health in 1999 has released a Traditional/Complimentary Medicine (TCM)  
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Policy with the emphasis of ‗rational use‘; the philosophy that emphasized on the 
concurrent use of traditional and modern medicines (Puteh, 1999). Currently, herbal plants 
such as Tongkat Ali (Eurycoma longifolia), Kacip Fatimah (Labisia pumila), Misai Kucing 
(Orthosiphon stamineus) and Hempedu Bumi, (Andrographis paniculata) hava gained 
extensive research interest locally. Off these plants, Misai Kucing, Orthosiphon stamineus 
and Hempedu Bumi, Andrographis paniculata have been extensively reported to their 
hepatoprotective activity besides their other medicinal values as well (Arif, 2002). C. 
xanthorrhiza, another local plant which has been widely used for anti-aging has also been 
traditionally claimed for its hepatoprotective activity (Herman, 1985).  
In this context, systematic investigation of the hepatoprotective activity of C. 
xanthorrhiza in in-vivo model is required to develop a satisfactory herbal therapy to treat 
liver diseases as to prove its traditional claims.  On the other hand, C. xanthorrhiza 
antinociceptive and antioxidant properties together with its toxicity effects are not well 
documented. With this in view and as part of this thesis, C. xanthorrhiza was selected for 
pharmacological evaluations.  
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 The plant C. xanthorrhiza  
2.1.1 Overview of C. xanthorrhiza  
C. xanthorrhiza Roxb. is a plant that belongs to ginger family (Zingiberaceae) of  
the genus Curcuma. C. xanthorrhiza is a native Indonesian plant, which is indicated by its 
synonym, namely Curcuma javanica (Arifin and Kardoyono, 1985). It is known as ‗Temu 
Lawak‘in Malaysia. Other common names of C. xanthorrhiza are Tumulawak, Java 
turmeric, and gedè. 
The cultivation of temulawak has spread over several islands such as Java, 
Moluccas islands and Kalimantan. Recently, due to its various medicinal qualities, 
cultivation of the plant is also found in several countries, such as Malaysia, Sri Lanka, 
India, Philippines and Thailand (Herman, 1985). The official documentation of temulawak 
in Indonesia was first written by Garcia ab Orta, a Portuguese, in 1563, while its activity 
was reported in detailed by Bontius, a Dutch doctor from Batavia. The Dutch, realizing its 
benefits, attempted to introduce C. xanthorrhiza as a seasoning and a drug component in 
Europe.  
Simultaneously, the popularity of temulawak began to increase, which was also 
followed by various researches on its activity as medicine. Prior to World War II, 
temulawak from Indonesia has been exported to Netherlands and Germany and to date, it is 
well known in several European countries. In those countries, temulawak is known as liver 
tea, because of its effects to cure various liver disorders (Herman, 1985). 
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2.1.2 Botanical description of C. xanthorrhiza 
C. xanthorrhiza is a low growing plant between 2 to 2.5 meters. It grows as a bush 
in wet semi-open areas, especially by roads and river with a root (rhizome) that is similar 
to ginger with aromatic, pungent odor and bitter taste. The large leaves are oblong in 
shape, thin and usually tufted. Leaves are deep green with purple central feather. Spites 
peduncled and bracts large ovate forming a cone with upper ones empty and lower ones 
have several fungacious flowers. Spike is lateral with short scape. Bracts are pale green 
with red–edged with uppermost red violet and base green striped. Flower of C. 
xanthorrhiza is pinkish with many petals and a green stalk.  
Curcumas usually have ordinary annual flowering especially during wet season. 
Based on the observation, C. xanthorrhiza flowering in Malaysia (Penang) occurs between 
November to December (Arifin and Kadaryono, 1985). It can be harvested after 8-12 
months, when the leaves turn yellowish. The tuber grows from stem and has dark-
yellowish (brownish) colour, 15 cm of length and 6 cm of diameters. This tuber smells 
balmy and tastes bitter. C. xanthorrhiza grows in low level ground up to 750 m above the 
sea (Arifin and Kardoyono, 1985). 
 
 
 
 
 
6 
 
 
Figure 2.1: C. xanthorrhiza Roxb plant 
.  
Figure 2.2: Leaves of C. xanthorrhiza Roxb.  
 
Figure 2.3: Rhizome (root) of C. xanthorrhiza Roxb.  
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2.1.3 Traditional uses of C. xanthorrhiza 
C. xanthorrhiza has been used for centuries in traditional system of medicine to 
treat several diseases. In folk medicine, C. xanthorrhiza is reported to be useful for 
hepatitis, liver complaints, diabetes, rheumatism, cancer, hypertension and heart disorders. 
C. xanthorrhiza has also shown diuretic, anti-cancer, anti-inflammatory, anti-oxidant, anti-
hypertensive, anti-rheumatic, anti-hepatotoxic, anti-dysmenorrheal, anti-spasmodic, anti-
leucorrhoea, anti-bacterial and antifungal effects. Traditionally, this plant which is 
available as an herbal drink prevents blood clots and increases the immune system 
(Herman, 1985). 
In Indonesia, Malaysia and Thailand, C. xanthorrhiza is considered as a panacea 
and is recommended in the treatment of abdominal complaints, liver disorders and gout 
attacks. C. xanthorrhiza is also used in traditional products for haemorrhoids, skin rashes, 
infected wounds and eczema as it contains anti-inflammatory properties. C. xanthorrhiza is 
very often utilized as an ingredient in ‗jamus‘ recipes which is a typical Indonesian kind of 
elixir or liquid remedy (Perry, 1980). 
In Southeast Asia, temulawak is a highly appreciated food ingredient because of its 
spicy and bitter taste, which is stronger than turmeric (Curcuma longa). Sliced rhizomes 
are cooked with vegetables; on the other hand the dried and cooked pieces are used to 
enhance flavors in soft drinks (Perry, 1980). 
2.1.4 Phytochemistry of C. xanthorrhiza 
Xanthorrhizol, the major component of the essential oil of C. xanthorrhiza, is a 
bisabolane-type sesquiterpenoid containing a stereogenic centre at the benzylic position. 
Xanthorrhizol is a potential chiral starting material for the synthesis of bisabolane-type 
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sesquiterpenoids as shown in Figure 2.4 (Rimpler et al., 1970). This compound makes up 
nearly 46.3% of the total component of essential oil through hydrodistillation technique 
(Cheah et al., 2009). Along with xanthorrhizol, bisabolane sesquiterpenes, a-curcumene, 
ar-turmerone and p-atlantone were isolated from the rhizomes of C. xanthorrhiza and they 
were reported to be the most active compounds (Itokawa et al., 1985). Studies have shown 
that xanthorrhizol can be used as a precursor for the synthesis of several other bisabolane-
type sesquiterpenoids, including the first enantioselective syntheses of triols, facile and 
short syntheses of curcuquinone, curcuhydroquinone, helibisabonol A and the epimer of 
helibisabonol A, as well as syntheses of the unnatural allylic alcohols (Sirat et al., 2007). 
Curcumin, a phenol compound is the second essential active chemical entity found 
in this plant as in Figure 2.5 (Ruslay et al., 2007). It comprises almost 1 to 2% in ethyl 
acetate fraction of C. xanthorrhiza. Several diarylheptanoids, curcumin (Kuroyanagi and 
Natori, 1970; Uehara et al., 1987), demethoxycurcumin (Kuroyanagi and Natori, 1970; 
Jitoe et al., 1992), bisdemethoxycurcumin (Kuroyanagi and Natori, 1970; Jitoe et al., 
1992), curcuminoid (Jitoe et al., 1992), dihydrocurcumin, octahydrocurcumin and 
hexahydrocurcumin (Uehara et al., 1987) have been isolated from the rhizomes of C. 
xanthorrhiza. Three non-phenolic diarylheptanoids were also isolated from the hexane 
extract of the rhizomes of C. xanthorrhiza and they were identified as 1, 7 dipheny1-1, 3-
heptadien-5-one, l, 7-diphenyl-l-hepten-5-ol and trans, l, 7-diphenyl- l, 3-heptadien-5-ol 
(Shin-Ichi et al., 1987). 
C. xanthorrhiza contains various active volatile substances such as germacrone, 
borneol and essential oils which are present in much lower quantities (Simon and Cherry, 
2006). 
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Figure 2.4: Xanthorrhizol chemical structure       Figure 2.5: Curcumin chemical structure 
 
2.1.5 Pharmacological activites of C. xanthorrhiza 
C. xanthorrhiza has been documented for its antidiuretic, anticancer, anti-
inflammatory, anti-oxidant, anti-hypertensive, anti-hepatotoxic, anti-spasmodic, anti-
bacterial and antifungal properties. Besides, it also reduces cholesterol in blood and liver, 
treats constipation, and increases flow of milk during breast feeding (Herman, 1985). 
Pharmacological activities of C. xanthorrhiza and its dominant compound, 
xanthorrhizol have been long recorded and reviewed since 1980‘s. Ozaki et al. (1990) has 
reported the anti-inflammatory properties of C. xanthorrhiza rhizomes where it inhibited 
the edema induced by carrageenan in rats. C. xanthorrhiza methanolic extract was known 
for its diuretic activities (Mahmood et al., 2004). The antioxidant activity of C. 
xanthorrhiza rhizomes was also not spared due to the presence of curcuminoids (Jitoe et 
al., 1992). 
There are several claims that C. xanthorrhiza has been used for its hepatoprotective 
purposes in folk medicine. This was supported by lowering of the serum enzyme levels 
such as alanine aminotransferases (SGPT), aspartate aminotransferases (SGOT) and y-
glutamate transferases  in  cisplastin induced hepatotoxicity rats given the C. xanthorrhiza 
extract (Seong et al., 2004). In addition, the hepatoprotective activity of aqueous extract of 
C. xanthorrhiza against β-D-galactosamine induced liver damage and alcohol has been 
reported by Lin et al. (1996) and Yasni et al. (1993) respectively.  
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A number of reports were found on the pharmacological activities of xanthorrhizol 
and curcumin, which are the major compounds identified in C. xanthorrhiza. 
Xanthorrhizol was investigated for its antibacterial (Hwang et al., 2000) and anticandidal 
activity (Rukayadi et al., 2006).  Lim et al. (2005) has reported on the anti-inflammatory 
effects of xanthorrhizol against neuronal cells. Potent insecticidal activity also has been 
reported on xanthorrhizol (Pandji et al., 1993).  Recently scientists have reported the anti-
metastatic potential of xanthorrhizol in experimental mouse lung metastasis models.  
Studies also showed that the simultaneous treatment of xanthorrhizol and curcumin 
exhibits synergistic effect towards human breast carcinoma cells (Cheah et al., 2009).   
Though numerous studies on the C. xanthorrhiza pharmacological properties have 
been reported, however the toxicity, hepatoprotective and analgesic properties are not well 
documented in literature. In this dissertation, detailed studies on above mentioned 
pharmacology properties were undertaken. 
2.2 Plant extraction method 
Extraction is the major step in the herbal drugs preparation. It requires raw material 
and extraction liquid or solvent. Extraction is the separation of the substances in a mixture, 
performed by dissolving each component with one or several solvents. It yields at least two 
components namely the solution extracted in the solvent (solute) and the residue. 
Extraction is completed when the concentration has reached a balanced level. Methanol or 
ethanol is commonly preferred solvents for extraction (Wichtl, 2004). There are distinct 
types of extraction procedures available. Among the extraction methods, the most regularly 
used is solid–liquid extraction, which consists of the privileged separation of one or more 
components of a solid mixture by dissolving them in a liquid solvent (Wichtl, 2004).  
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On the other hand, liquid-liquid extraction is another very common method 
employed in the organic laboratory. It is often used as the initial step in the work-up of a 
reaction, before final purification of the product by recrystallization, distillation or 
sublimation (Houghton and Raman, 1998). Immiscible liquids involved in solvent-solvent 
extraction resulting in the formation of two different layers. Various component of the 
mixture possess solubility in each of the two layers and achieves concentration equilibrium 
at a certain time. 
 Liquid-liquid extraction will be initiated with low and completed with high 
polarity solvents in order to extract out specific classes of compounds at each stage 
(Houghton and Raman, 1998). For example, low polarity solvents such as hexane, light 
petroleum and toluene will be good choice of solvents to extract waxes, fats and fixed oils. 
While ethyl acetate, butanol, diethyl ether and acetone are categorized under medium 
polarity solvents to isolate alkaloids, flavonoids and aglycones (Houghton and Raman, 
1998). Ultimately, high polarity solvents like water, aqueous acids and bases are used to 
separate sugars and amino acids. Some common liquid-liquid extraction solvent pairs are 
water-ethyl acetate, water-butanol, water-hexane or water-dichloromethane. Each solvent 
combination contains water since water is highly polar and immiscible with most organic 
solvents (Houghton and Raman, 1998). 
2.3 Standardization of plant sample 
Plant drugs are plant-derived medicines containing a chemical compound or more 
usually mixtures of chemical compounds that act individually or in synergistic manner to 
maintain health (Gurib-Fakim, 2006). Pure compounds or chemical entities are either 
isolated from natural products or made by synthesis in the laboratory. Herbal teas, 
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decoction, alcoholic extracts are also traditional ways of using medicinal plants. These 
plant materials are often utilized in a non-standardized manner. However, the use of 
standardized materials in herbal medicine is being emphasized in recent years (Gurib-
Fakim, 2006). 
 Standardization is a method of assuring a consistent level of active ingredients in 
the extract and only applies to extracts in the ﬁeld of phytomedicines. It is important as a 
way of ensuring a consistent supply of high-quality phytopharmaceutical products. It can 
be deﬁned as the establishment of reproducible pharmaceutical quality by comparing a 
product with established reference substances. Monographs and pharmacopeias provide the 
standards for active ingredients to be used in medicinal products. These phytodrugs turn 
out to be medicines when they are registered and comply with the basic established 
standards (Gurib-Fakim, 2006) 
Standardization can be carried out by obtaining a chemical fingerprint/profile or through 
bioactivity guided fractionation to obtain marker compounds. It would be ideal to use the 
active constituent in the plant as the marker compound. Yet, in cases where active 
constituents are not known, the marker compound can be independent of the therapeutic 
activity. Furthermore, the plant extracts can also be standardized to class of compounds, 
for instances, ginsenosides in ginseng, kava lactones in kava, or oxindole alkaloids in cat‘s 
claw (Roman, 2001). Such approach would be suitable for situations where the active 
constituents are not known but expected to belong to a particular class of compounds. 
According to European Medicines Agency guidelines, quantification of substances 
with known therapeutic activity or markers is essential (Roman, 2001). As per the 
European Pharmacopoeia, marker compounds should be unique for the herbal material or 
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herbal preparation and includes established chemical structures.  Analytical tools such as 
thin layer chromatography (TLC), high performance liquid chromatography (HPLC), gas 
chromatography (GC), liquid chromatography (LC), high-performance TLC (HPTLC), 
over-pressured layer chromatography (OPLC), infrared and UV-VIS spectrometry, nuclear 
magnetic resonance (NMR), electrophoretic techniques, especially by hyphenated 
chromatography, are often used for standardization and to control the quality of both the 
raw material and the finished product. The results extracted from these sophisticated 
techniques provide a chemical fingerprint as to the nature of chemicals or impurities 
present in the plant or extract (WHO, 2002; Bilia et al., 2002). 
Standardization is necessary with the remarkable increase in the global use of 
medicinal plants related to several concerns that has been raised regarding the efficacy and 
safety of the herbal medicines. Hence it has become necessary to standardize the quality of 
the plant material and to increase the level of trust people have in herbal drugs (Brunton, 
2006).  
2.4 Toxicity and Adverse Effects 
Plants contain hundreds of constituents and some of the constituents are very toxic 
and can be detrimental, for instances; digitalis, the pyrrolizidine alkaloids, ephedrine, 
phorbol esters which are categorized under the most cytotoxic anti-cancer plant-derived 
drugs. The adverse effects of most herbal drugs are rather less frequent when the drugs are 
utilized appropriately compared with synthetic drug (Stewart et al., 1998; Schimmer et al., 
1994). 
 In short, herbs are medicines which are effective in appropriate quantities and  may 
cause side effects if taken in high amount or prolonged exposure. Evaluation of toxic 
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properties of a substance is crucial when considering for public health protection. In 
practice, the evaluation typically includes acute, sub-chronic, chronic, carcinogenic and 
reproductive effects (Asante-Duah, 2002).   
2.4.1 Brine shrimp lethality assay 
The brine shrimp assay has been recognized as a safe, practical, and economic 
method for the determination of the bioactivity of synthetic compounds (De Almeida et al., 
2002) as well as plant products (Meyer et al., 1982; McLaughlin et al., 1991; Lhullier et 
al., 2006). It is an in vivo lethality test in a simple zoologic organism that can be used as a 
convenient monitor for screening and fractionation in the discovery of bioactives (Lhullier 
et al., 2006).  
Brine shrimp Artemia salina L. (Artemiidae), is an invertebrate component of the 
fauna of saline aquatic and marine ecosystems. It plays a significant role in the energy flow 
of the food chain. Besides, it is being widely utilized in laboratory bioassay to determine 
the toxicity by estimating the median lethal concentration (LC50) which has been reported 
for a series of toxins and plant extracts (Meyer et al., 1982). Identification of the lethal 
concentration for 50% mortality after 6 hours of exposure (the acute LC50）makes the test 
rapid, simple and effective to determine the toxicity level of C. xanthorrhiza extract. 
2.4.2 Acute oral toxicity  
Acute oral toxicity is an initial and a requisite step in the assessment and evaluation 
of the toxic characteristics of a substance. Acute oral toxicity is the adverse effects 
occurring within a short time of single or multiple doses of a substance via oral route 
within 24 h of administration (OECD 401, 2001b). Acute oral toxicity testing in animal 
models provides information on the biological activity of a substance (plant or chemical) 
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and gain insight into its mechanism of action. Acute toxicity is distinguished from chronic 
toxicity, which describes the adverse health effects from repeated exposures, often at lower 
levels, to a substance over a longer time period (months or years) (OECD 401, 2001b). 
  It is widely considered unethical to use humans as test subjects for acute (or 
chronic) toxicity research. However, some information can be attained from investigating 
accidental human exposures, for example; factory accidents. Otherwise, most acute 
toxicity data can be obtained from animal testing or in vitro testing. The current OECD 
guidelines recommends the use of small number of animals since authorities today do not 
usually demand classical LD50 tests (OECD 401, 2001b). 
The LD50 (median lethal dose) value is defined as the statistically derived dose which 
is expected to cause death in 50% of the treated animals in a given period in an acute 
toxicity test. This is the basis for toxicologic classification of chemicals. For a classical 
LD50 study, laboratory mice and rats are the species of choice. In this thesis, acute toxicity 
study was investigated for C. xanthorrhiza extract to ensure the safety of this plant 
product. 
2.5 Antinociceptive activity 
2.5.1 Pain definition and types of pain  
Pain is a complex experience, initiated by unpleasant sensory information from an 
unpleasant stimulus which is associated with potential tissue damage (Turk and Dworkin, 
2004). It is a major symptom in many medical conditions, and can significantly interfere 
with a person's quality of life and general functioning (Turk and Dworkin, 2004).  
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In general, pain can be divided into two major categories namely good pain 
(protective) and bad pain (maladaptive). Good pain is commonly designated as acute pain 
or known as eudynia. It is protective in nature and reduces in intensity as the tissue returns 
to normal. Chronic pain states often occur due to structural or functional changes in the 
nervous system. This type of pain can be defined as maldynia or bad pain. Chronic pain 
states often occur due to structural or functional changes in the nervous system (Cervero, 
2006). 
In short, acute pain is an expected symptom of a problem that typically will resolve 
with time while chronic pain represents an unexpected disease that is a pathologic entity 
and can be prolonged by triggered stimulus (Cervero, 2006). 
2.5.2 Nociceptive Pain Mechanism 
Nociceptive pain is related to the processing of noxious stimuli in the nervous 
system (Lynn, 1996; Schaible et al., 2005). It is due to the activation of the nociceptive 
system by noxious stimuli arising from mechanically, chemically or thermally induced 
damage to tissue integrity (Woolf, 2004). In general, the nociceptive pain pathway consists 
of four processes inclusive of transduction, conduction, transmission, and perception 
(Woolf, 2004). The nociceptive system originates in peripheral nerve fibers that respond to 
stimuli exceeding harmful intensity, spans the spinal cord, traverses the brain stem and 
thalamus and eventually terminates in the cerebral cortex, where the sensation of pain is 
perceived. Peripheral tissues are innervated by nociceptors, highly specialized primary 
sensory neurons, which contain specific receptors or ion channels at their peripheral 
terminals (Woolf, 2004; Scholz and Woolf, 2002).  
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There are different classes of nociceptors and these react to different types of 
stimuli depending on the types of receptors or ion channels they contain. The A-delta fiber 
and the C-fiber nociceptors are the two main classes of nociceptors. C-fibers are the most 
common which comprises 70 % of the fibers. Their axons are unmyelinated with small cell 
bodies. C-fibers conduct action potentials slowly when activated, resulting in prolonged 
burning pain. A-delta fibers consist of thinly myelinated axons with medium- to large-
diameter cell bodies. They conduct impulses at a faster rate and produce sharp, pricking 
pain when activated (Stucky et al., 2001).  The pain system involves a set of ascending 
pathways that convey nociceptive information from peripheral nociceptors to higher levels 
of the central nervous system, as well as descending pathways that modulate that 
information (Bromm and Desmedth, 1995). This can be referred as ‗Gate Control Theory‘ 
which was developed by Melzack and Wall (1965).  
2.5.3 Peripheral sensitization 
Peripheral sensitization involves inflammation which involves a cascade of events. 
During inflammation, polymodal nociceptors are sensitized. In normal tissue, these fibers 
contain high mechanical and thermal thresholds in normal tissue. In this case, high 
intensity stimuli are required to excite those fibers. However, in course of inflammation, 
this threshold drops where even a mild stimuli is able to activate the fibers. Thus, 
sensitized ―pain fibers‖ are activated by non-painful stimuli resulting in pain eventually 
(Handwerker, 1999; Schaible and Schmidt, 1988). 
In addition, inflammation is also able to recruit silent nociceptors. These silent 
nociceptors are known as C-fibers that are inexcitable by noxious mechanical or thermal 
stimuli in normal tissue. Though, during inflammation, these primary mechanosensitive 
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fibers are sensitized, and are activated by stimuli (Schaible and Schmidt, 1988). In short, 
pathophysiological nociceptive input to the spinal cord is generated by the enhanced 
activity of sensitized polymodal nociceptors and the recruitment of silent nociceptors.  
The sensitization during inflammation is induced by the action of inflammatory 
mediators on the nociceptors. A large number of inflammatory mediators are produced and 
released in the passage of inflammation and cause several classical signs of inflammation 
such as swelling, redness, hyperthermia, and pain (Kress and Reeh, 1996).  This 
inflammatory soup includes endothelin, prostaglandin E2, leukotrienes, bradykinin, 
cytokines, serotonin and adrenaline which are released following tissue injury and causes 
increased excitability by activating the second messengers cascades (Bevan, 1996). Mast 
cells, macrophages and neutrophils discharge a number of proinflammatory substances.   
Further, voltage-gated sodium channels and the capsaicin receptor are also involved 
in activation and sensitization of peripheral nociceptors. Besides, cyclic adenosine 
monophosphate (cAMP), protein kinases and neurotrophic factors (Lewin et al., 1994) 
play a significant role in the sensitizing action of many inflammatory mediators (Chapman 
and Garvin, 1999). 
2.5.4 Testing for antinociceptive properties 
The term nociception is used to refer to the studies being conducted on laboratory 
animals. The crucial in developing laboratory animal models of pain has been attempted to 
reproduce or mimic pain in humans. Pain can be studied in primates and other mammals, 
but the rodent models are preferred and most widely used (Bars et al., 2001). The rat or 
mouse is usually the preferred species in animal models (Fleetwood et al., 1999).In 
conjunction with this, a number of tests have been devised to evaluate basal pain 
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sensitivity for example, the reaction of a normal or naive animal to graded-strength 
mechanical, thermal, or chemical stimuli (nociceptive pain) (Woolf and Max, 2001). 
Nociceptive pain can be divided into acute nociceptive stimulus (somatic model 
pain) and those are concerned with medium or long term responses associated with 
inflammation (visceral or tonic pain). Ultimately, somatic pain is caused by stimuli such as 
cutting or crushing resulting in acute and sharp pain (Steeds, 2009) .The tests designed for 
acute nociception includes the tail flick, tail immersion, hot plate, radiant heat and laser 
irradiation (Siddall and Munglani, 2003).The most common and widely utilized thermal 
methods in laboratory are hotplate and tail flick tests. Hot plate thermal method is suitable 
for evaluation of centrally acting and not peripherally acting analgesics. The hot-plate test, 
initially invented by Eddy and Leimbach (1953), evaluates thermal pain reflexes due to 
footpad contact with a heated surface. Tail flick tests or known as radiant heat method is 
used for quantitative measurement of pain threshold against thermal radiation exposed on 
rat‘s tails and to discriminate between centrally acting morphine-like analgesics and non-
opiate analgesics (D‘amour and Smith, 1941). Tail flick depends on both spinal and 
supraspinal reflexes under different conditions (King et al., 1997). Spinal reflex is 
exhibited when an intense heat source is used while supraspinal system comes when heat 
intensity decreased (Jensen and Yaksh, 1986). Therefore, different neural system in the 
central pathway may mediate tail flick responses (Karoly and Jensen, 1987), In short, both 
hot plate and tail flick assess the central acting acute pain by stimulating the peripheral 
axons, including thermosensitive and nociceptors fibers (Bars et al., 2001). 
Visceral pain describes the pain which is persistent and emanated from deep 
visceral structures. Viscera seem to be most sensitive to distention of hollow muscular-
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walled organs (including the gastrointestinal tract, urinary tract, gallbladder), ischemia (the 
myocardium in human patients), and inflammation (cystitis or pancreatitis) (McMahon et 
al., 1995). The visceral model of pain can be categorized in several ways which includes: 
(1) persistent central pain (induced by topical capsaicin or subcutaneous formalin); (2) 
chronic inflammatory pain (induced by Freund‘s complete adjuvant (FCA), carageenan 
and turpentine or UV-irradiation); (3) chronic neuropathic pain by damage or disturbance 
to peripheral nerve (can be induced by Bennett model, Seltzer model, Chung‘s model) 
(Fleetwood et al., 1999; Siddall and Munglani, 2003). Formalin test has been proposed as a 
chronic or visceral pain model (Cowan, 1989). The formalin tests identify mainly central 
and peripheral acting analgesic drugs (Dubuisson and Dennis, 1977). It also allows 
dissociation between inflammatory and non-inflammatory pain according to their site and 
mechanism of action (Chau, 1989). Tjolsen et al. (1992) described the early phase related 
to direct activation of peripheral small afferent fibers. The late phase known to be closely 
related to early phase nociception and is dependent on the activity in primary afferent 
neurons to produce neurogenic inflammation. 
Hence, hot plate and tail flick tests (somatic pain model) along with formalin tests 
(tonic pain and inflammation model) has been used to screen and evaluate the analgesic 
activity of C. xanthorrhiza. 
2.5.5 Plant as analgesics 
Analgesics have been estimated to be one of the highest therapeutic categories on 
which research efforts are concentrated (Elisabetsky and Castilhos, 1990). Analgesic 
compounds available in the market still outline a wide range of undesired effects (Katzung 
et al., 1998)  leaving an open door for novel and better compounds. Natural products are 
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believed to be a vital source of new chemical substance with potential therapeutic 
applicability. Several plant species has been traditionally claimed and utilized as analgesics 
(Mills and Bone, 2000). Reports are available about analgesic effects of medicinal plants in 
the literatures such as Mangifera indica, Curcuma longa L. (turmeric), Zingiber officinale 
(ginger), Salix alba and Sida cordofolia. (Garrido et al., 2001; Ammon et al., 1992; Santa 
Maria et al., 1997;Li et al., 2002; Suthradhar et al., 2006).  
 Analgesic, also known as a painkiller belongs to the diverse group of drugs used to 
relieve pain. Analgesic drugs may act in various ways on the peripheral and central 
nervous systems as described in pain physiology. There are few types of analgesics 
available including the non-steroidal anti-inflammatory drugs (NSAIDs) such as the 
salicylates, narcotic drugs such as morphine, synthetic drugs with narcotic properties for 
example tramadol, and non-acidic anti-pyretic derivatives namely paracetamol (Dworkin et 
al., 2003). 
Non-steroidal anti-inflammatory drugs, usually abbreviated to NSAIDs, are drugs 
containing analgesic and anti-inflammatory properties. Aspirin, one of the most common 
NSAID drugs used to relieve minor aches and pains, as an antipyretic to reduce fever and 
anti-inflammatory medication. Aspirin was the first discovered member of the class of 
drugs as well as non-steroidal anti-inflammatory drugs (NSAIDs), capable of inhibiting the 
enzyme cyclooxygenase (COX) as their mechanism of action. Today, aspirin is one of the 
most widely used medications in the world (Reimann and Schneider, 1998).  
Aspirin is widely utilized as an anti-inflammatory drug due to its ability to suppress 
the production of prostaglandins and thromboxanes. Prostagladins and thromboxanes are 
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mediators involved in peripheral sensitization resulting in inflammation ultimately. COX is 
required for prostaglandin and thromboxane synthesis. In this case, aspirin plays a role in 
the irreversible inactivation of the COX enzyme by acting as an acetylating agent where an 
acetyl group is covalently attached to a serine residue in the active site of the COX 
enzyme. Basically, aspirin inhibits COX-1 and modify the enzymatic activity of COX-2 
which suppresses the inflammation injury (Bamigbade et al., 1997). 
Opiates are narcotic type of opioid alkaloids found in opium poppy, Papaver 
somniferum.  Morphine is the most prevalent alkaloid in opium, comprising of 10% to 16% 
of the total mass and has been reported to possess narcotic analg esic properties. It exhibits 
analgesic effects by binding to opioid receptors in the central nervous system and the 
gastrointestinal tract. There are three main classes of opioid receptors, μ, κ, δ (mu, kappa, 
and delta) respectively. Morphine binds strongly to the μ-opioid receptors resulting in 
analgesic and sedation effects. κ-opioid is associated to spinal analgesia and δ-opioid plays 
a role in analgesia (Klawe and Maschke, 2009). Aspirin and morphine have been used as 
standard reference drugs to evaluate antinociceptive properties of C. xanthorrhiza extract 
in this work. 
2.6 Antioxidant activity 
2.6.1 Plant antioxidants as natural defense  
Fundamentally, an antioxidant can be referred as a molecule capable of inhibiting 
the oxidation of other molecules. Oxidation is defined as a chemical reaction that transfers 
electrons from a substance to an oxidizing agent resulting in free radicals (Sies, 1997). 
Consecutively, these radicals are able to start chain reactions in a cell, which can lead to 
23 
 
damage or death. Here, antioxidant plays an important role in terminating these chain 
reactions by eradicating free radical intermediates, and inhibit other oxidation reactions. 
This eradication is done by antioxidants by oxidizing themselves, therefore antioxidants 
are often reducing agents namely thiols, ascorbic acid or polyphenols (Sies, 1997).
 
Since oxidation reactions can be damaging, plants and animals maintain a complex 
antioxidant systems with multiple types of naturally occurring antioxidants, such as 
glutathione, vitamin C, and vitamin E as well as enzymes, for example catalase, superoxide 
dismutase and various peroxidases (Valko et al., 2007). 
As oxidative stress appears to be a vital part of many human diseases, the use of 
antioxidants in pharmacology is extensively studied. Antioxidant compounds of foods and 
plants play an imperative role as a health protecting factor. Primary sources of naturally 
occurring antioxidants are whole grains, fruits and vegetables (Cao et al., 1993).  Plant 
sourced food antioxidants such as vitamin C, vitamin E, carotenes, phenolic acids, phytate 
and phytoestrogens have been known to have the potential to lessen disease risk. Most of 
the antioxidant compounds found in typical diet are derived from plant sources (Kuhnau, 
1976). They belong to various classes of compounds with a wide variety of physical and 
chemical properties. For example, compounds such as gallates, possess strong antioxidant 
activity, while others, like the mono-phenols are weak antioxidants (Cao et al., 1993).  
Besides, antioxidant compounds categorized in phenolic acids, polyphenols and 
flavonoids groups are able to scavenge free radicals such as peroxide, hydroperoxide or 
lipid peroxyl and eventually constrain the oxidative mechanisms that lead to degenerative 
diseases (Kuhnau, 1976). There are a number of clinical studies and ongoing research 
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being conducted on the antioxidant capacity of herbs, food and natural products. Some 
studies have reported that the antioxidants in fruits, vegetables, tea and red wine are the 
main factors for their efficiency in reducing the incidence of chronic diseases including 
heart disease and some cancers (Miller et al., 2000). The antioxidant activity of C. 
xanthorrhiza has been reported by Jitoe et al. (1992). 
2.6.2 Reaction mechanisms in antioxidant assays 
Principally, there are two major mechanisms involved in the deactivation of 
radicals by antioxidants namely hydrogen atom transfer (HAT) and single electron transfer 
(SET). In this both cases, same end results can be achieved; however kinetics and potential 
for side reactions differ. Bond dissociation energy (BDE) and ionization potential (IP) are 
two foremost factors that determine the mechanism and the efficacy of antioxidants 
(Wright et al., 2001).  
HAT-based methods measure the classical ability of an antioxidant to quench free 
radicals by hydrogen donation. This antioxidant reactivity or capacity measurements are 
based on competition kinetics. HAT reactions are solvent and pH independent. They are 
usually quite speedy, normally can be accomplished in sec to min. Yet, the presence of 
reducing agents, including metals, is a difficulty in HAT assays and can lead to 
erroneously high apparent reactivity (Wright et al., 2001).  
Whereas, SET-based methods detect the ability of a potential antioxidant to transfer 
one electron to reduce any compound, including metals, carbonyls, and radicals (Wright et 
al., 2001). SET reactions are usually slow and can necessitate longer time to reach 
completion (Sartor et al., 1999). SET methods are very sensitive to ascorbic acid and uric 
acid, which are significant in maintaining plasma redox tone, and reducing polyphenols are 
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also spotted. Prominently, trace components and contaminants (particularly metals) 
interfere with SET methods and can account for high variability and poor reproducibility 
and reliability of results. SET and HAT mechanisms almost always take place together in 
all samples, with the balance determined by antioxidant structure and pH respectively (Ou 
et al., 2002). 
Various in-vitro antioxidant methods with distinct reaction mechanism have been 
employed to monitor and compare the antioxidant activity of foods, plants, natural 
products and biological fluids. These methods require special equipment and technical 
skills for the analysis. Such methods that are performed to explore the antioxidant activity 
of C. xanthorrhiza are total phenolics and flavonoids content based on oxidation or 
reduction reaction, FRAP assay which is based on SET mechanism, DPPH scavenging 
activity and ABTS assay that complies both HAT and SET mechanism. 
2.6.3 Total phenolic and flavonoids assays 
Phenolics are ubiquitous secondary metabolites in plants. They comprise a large 
group of biologically active ingredients, above 8000 compounds which varies from simple 
phenol molecules to polymeric structures with molecular mass above 30,000 Da (Harbone, 
1982). Basically, the modern classification forms two basic groups of phenolics namely 
simple phenols and polyphenols. The group of simple phenols includes ‗phenolic acids‘ or 
phenols with carboxyl group underlying the specificity of their function. While, 
polyphenols contains at least two phenol rings structurally. 
 Based on their carbon skeleton, polyphenols were classified in non-flavonoid 
compounds (eg: stilbenes, hydroxycinnamic acids and benzoic acids) and flavonoid 
compounds. More than 4,000 flavonoids have been identified in variety of higher and 
